ストックスクリーナーアプリを入手
6.07
3.19%
-0.20
Coya Therapeutics Inc (COYA) 最新ニュース
Is Coya Therapeutics Inc. stock poised for growthTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
Is now a turning point for Coya Therapeutics Inc.Portfolio Return Summary & Precise Buy Zone Tips - newser.com
What data driven models say about Coya Therapeutics Inc.’s futureBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Candlestick signals on Coya Therapeutics Inc. stock todayQuarterly Profit Review & Safe Entry Trade Reports - newser.com
Should you hold or exit Coya Therapeutics Inc. nowTrade Volume Summary & Fast Entry High Yield Tips - newser.com
Quantitative breakdown of Coya Therapeutics Inc. recent move2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
News impact scoring models applied to Coya Therapeutics Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com
What momentum shifts mean for Coya Therapeutics Inc.Quarterly Investment Review & Low Volatility Stock Suggestions - newser.com
Coya Therapeutics (NASDAQ:COYA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Published on: 2025-10-09 03:57:14 - newser.com
Ranking Coya Therapeutics Inc. among high performing stocks via tools2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
Coya Therapeutics Congratulates Scientific Advisor Dr. Shimon Sakaguchi for Receiving The Nobel Prize in Physiology or Medicine for Discovery of Regulatory T Cells and Immune Function - BioSpace
What analysts say about Coya Therapeutics Inc stockPrice Momentum Alerts & Budget Friendly Portfolio Growth - earlytimes.in
Predicting Coya Therapeutics Inc. trend using moving averages2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
What sentiment indicators say about Coya Therapeutics Inc. stockWeekly Risk Report & Community Consensus Picks - newser.com
How to integrate Coya Therapeutics Inc. into portfolio analysis toolsWeekly Trading Summary & Stock Portfolio Risk Management - newser.com
Will Coya Therapeutics Inc. stock outperform value stocksPrice Action & Risk Controlled Daily Trade Plans - newser.com
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives $16.20 Consensus PT from Analysts - Defense World
What drives Coya Therapeutics Inc stock priceDividend Yield Trends & Trusted Financial Advisors at No Cost - earlytimes.in
BTIG Reiterates Buy Rating on COYA with $15 Price Target | COYA Stock News - GuruFocus
Coya Therapeutics (NASDAQ:COYA) Receives Buy Rating from BTIG Research - MarketBeat
Positive Outlook for Coya Therapeutics Driven by Promising COYA-302 Clinical Developments and Regulatory Support - TipRanks
Coya completes FTD combination therapy trial enrolment - Yahoo Finance
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
D. Boral Capital Maintains Coya Therapeutics (COYA) Buy Recommendation - Nasdaq
Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Frontotemporal Dementia - Quantisnow
COYA Stock Analyst Rating: D. Boral Capital Maintains "Buy" Rati - GuruFocus
Coya Therapeutics' (COYA) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
Coya Therapeutics announces completion of patient enrollment - MarketScreener
Coya Therapeutics, Inc. Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Patients with Mild to Moderate Frontotemporal Dementia - MarketScreener
Coya Therapeutics (NASDAQ:COYA) Trading Up 3.4%Should You Buy? - MarketBeat
Coya Therapeutics (NASDAQ:COYA) Trading Up 3.4% – Should You Buy? - Defense World
Is Coya Therapeutics Inc. forming a bottoming base2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
New trial to test effectiveness of COYA 302 to slow ALS progression - ALS News Today
5.74%
大文字化:
|
ボリューム (24 時間):